Welcome to our dedicated page for The Beauty Health Company SEC filings (Ticker: SKIN), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Finding how much HydraFacial’s revenue comes from high-margin serums versus capital equipment can feel like searching for a pore in the dark. The Beauty Health Company annual report 10-K simplified still runs well over 200 pages, and critical warranty, margin, and supply-chain details rarely sit in one place. If you have ever typed “The Beauty Health Company SEC filings explained simply” after another late-night scroll through footnotes, you are not alone.
Stock Titan removes that friction. Our platform ingests every disclosure the moment it hits EDGAR and delivers plain-English answers to the questions professionals actually ask, from “understanding The Beauty Health Company SEC documents with AI” to “The Beauty Health Company quarterly earnings report 10-Q filing.” You will see:
- Real-time alerts on The Beauty Health Company Form 4 insider transactions—watch executive stock moves minutes after they file.
- At-a-glance breakouts of consumable-versus-device sales inside each 10-Q.
- One-click access to The Beauty Health Company proxy statement executive compensation with AI commentary on incentive metrics tied to HydraFacial unit growth.
Need “The Beauty Health Company 8-K material events explained” when a new product launches? Want a single dashboard for The Beauty Health Company insider trading Form 4 transactions as well as “The Beauty Health Company executive stock transactions Form 4” in real-time? Or perhaps a concise “The Beauty Health Company earnings report filing analysis” before the market opens? Our AI-powered summaries highlight segment margins, recurring revenue ratios, and geographic trends so you can act quickly instead of parsing PDF jargon. Save hours, spot opportunities, and stay ahead with comprehensive coverage—every filing, every time.
The Beauty Health Company appointed Hatem Malha as President, CEO and director and disclosed the material terms of his employment agreement. His base salary will be $800,000 per year (pro-rated if partial year). He will receive a $450,000 one-time cash bonus payable within 14 days of the effective date that is repayable if he resigns without specified cause or is fired for cause within 12 months. He is eligible for an annual performance bonus targeted at 125% of base salary and two one-time equity awards: an Initial equity grant of $2,556,000 split 75% in RSUs and 25% in PSUs, and a 2025 equity grant of $2,000,000 split 75% RSUs and 25% PSUs, each subject to board approval and the company's Incentive Plan vesting terms.
Mirabella Financial Services LLP reported beneficial ownership of 12,790,383 shares of Beauty Health Company (common stock), representing 10.21% of the class. The filing states these shares are held on behalf of Blue Riband Fund LP, for which Mirabella acts as investment manager and has sole voting and dispositive power over the reported shares. The filing notes the holdings were acquired in the ordinary course of business and not for the purpose of changing or influencing control. The issuer's principal executive office is listed in Long Beach, California.
The Beauty Health Company (SKIN) filed a Current Report on Form 8-K reporting a material event dated September 4, 2025. The filing incorporates by reference a Supplemental Indenture No. 1 dated September 4, 2025 among The Beauty Health Company, the guarantors party thereto and U.S. Bank Trust Company, National Association, acting as trustee and collateral agent. The document includes an exhibit list and an embedded Inline XBRL cover page data file. The report is signed by Michael Monahan, Chief Financial Officer.
Janus Henderson Group plc reports beneficial ownership of 5,718,565 shares of The Beauty Health Company, representing 4.5% of the class. The filing indicates shared voting and shared dispositive power over those shares while noting no sole voting or dispositive power. The reporting person is organized in Jersey and identified as an investment adviser/holding company (IA, HC). The statement also discloses that indirect subsidiaries (JHIUS, JHIUKL and JHIAIFML) act as registered investment advisers providing advice to Managed Portfolios.
The Beauty Health Company (SKIN) Form 4 reports a non-sale withholding of shares by Chief Financial Officer Michael P. Monahan related to the vesting of restricted stock units. On 08/10/2025, 32,357 shares were withheld to satisfy tax withholding at a recorded price of $1.89 per share. The disclosure states this withholding "does not represent a sale." Following the transaction, the reporting person’s beneficial ownership is shown as 1,326,305 shares.
This filing documents an internal compensation settlement (tax withholding on vested RSUs) rather than an open-market transaction, and it clarifies the officer’s post-transaction share count.
Form 4 Overview – The Beauty Health Company (SKIN)
Director Desiree Gruber filed a Form 4 reporting the award of 73,051 Class A common-stock RSUs on 16 June 2025. The award was coded “A” (acquired) and represents equity compensation rather than an open-market purchase. After this grant, Gruber’s total beneficial ownership rises to 192,565 shares, all held directly.
Vesting Terms
- The RSUs vest on the earlier of (i) the one-year anniversary of the grant date or (ii) the 2026 annual meeting of shareholders.
- Continuous board service is required through the vesting date.
Key Takeaways for Investors
- The filing signals continued board-level alignment with shareholders, although the grant is part of the regular director compensation program rather than a discretionary purchase.
- No derivative securities transactions were reported, and no shares were disposed of.
- The transaction does not alter the company’s cash position or share count today, but it will have a modest dilutive effect upon vesting.